Tumour trap: engineered enhancer sequences enlisted to kill cancer cells Summary Researchers report a targeted viral strategy that uses engineered enhancer sequences — synthetic “super-enhancers” — to drive expression of…
Mapping the maternal–fetal interface through pregnancy in high resolution Summary This Nature Research Briefing summarises a high-resolution single-cell and spatial transcriptomics study (Wang et al.) that maps the human maternal–foetal…
Meta’s New AI Model Gives Mark Zuckerberg a Seat at the Big Kid’s Table Summary Meta has announced Muse Spark, its first major model since reorganising AI work under Meta…
The US Army Is Building Its Own Chatbot for Combat Summary The US Army is developing an AI chatbot, trained on real mission data, intended to provide soldiers with mission-critical…
Anthropic’s New Product Aims to Handle the Hard Part of Building AI Agents Published: 2026-04-08T17:00:00+00:00 | Source: WIRED Summary Anthropic has launched Claude Managed Agents, a hosted product that supplies…
Passport numbers for more than 300,000 leaked during December Eurail data breach Summary Eurail B.V. has notified US regulators that a December 26 security breach exposed personal data for 308,777…
Breach exposes sensitive LAPD files stored in city attorney system Summary Hackers gained access to a digital storage system belonging to the Los Angeles City Attorney’s Office that contained discovery…
Synthetic super-enhancers enable precision viral immunotherapy Article Date: 08 April 2026 Article URL: https://www.nature.com/articles/s41586-026-10329-6 Article Image: https://www.nature.com/articles/s41586-026-10329-6/figures/1 Summary The authors design and validate synthetic super-enhancers (SSEs) that drive highly selective,…
Hidden human–virus interactions uncovered in DNA in blood and saliva Summary Researchers scanned DNA sequence data from blood and saliva samples in large biobanks to measure the abundance of viral…
Genetics reveal why people respond differently to GLP-1 weight-loss drugs Summary Researchers are uncovering genetic reasons why people vary in their response to GLP-1-based anti-obesity medicines. Variants in the GLP1R…
